These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 29551286)
1. Up-regulation of microRNA-93 inhibits TGF-β1-induced EMT and renal fibrogenesis by down-regulation of Orai1. Ma J; Zhang L; Hao J; Li N; Tang J; Hao L J Pharmacol Sci; 2018 Apr; 136(4):218-227. PubMed ID: 29551286 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN. Xu H; Sun F; Li X; Sun L Hum Cell; 2018 Jan; 31(1):22-32. PubMed ID: 28707079 [TBL] [Abstract][Full Text] [Related]
3. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517 [TBL] [Abstract][Full Text] [Related]
4. Let-7d miRNA prevents TGF-β1-induced EMT and renal fibrogenesis through regulation of HMGA2 expression. Wang Y; Le Y; Xue JY; Zheng ZJ; Xue YM Biochem Biophys Res Commun; 2016 Oct; 479(4):676-682. PubMed ID: 27693697 [TBL] [Abstract][Full Text] [Related]
5. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice. Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848 [TBL] [Abstract][Full Text] [Related]
6. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy. Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566 [TBL] [Abstract][Full Text] [Related]
7. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation. Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195 [TBL] [Abstract][Full Text] [Related]
8. Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells. Wang Y; Fu B; Sun X; Li D; Huang Q; Zhao W; Chen X Stem Cell Res Ther; 2015 Sep; 6():185. PubMed ID: 26415502 [TBL] [Abstract][Full Text] [Related]
9. MiR-448-5p inhibits TGF-β1-induced epithelial-mesenchymal transition and pulmonary fibrosis by targeting Six1 in asthma. Yang ZC; Qu ZH; Yi MJ; Shan YC; Ran N; Xu L; Liu XJ J Cell Physiol; 2019 Jun; 234(6):8804-8814. PubMed ID: 30362537 [TBL] [Abstract][Full Text] [Related]
10. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy. Gao BH; Wu H; Wang X; Ji LL; Chen C Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183 [TBL] [Abstract][Full Text] [Related]
12. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells. Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323 [TBL] [Abstract][Full Text] [Related]
13. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression. Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937 [TBL] [Abstract][Full Text] [Related]
15. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway. Zhang Y Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484 [TBL] [Abstract][Full Text] [Related]
16. miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Wang B; Koh P; Winbanks C; Coughlan MT; McClelland A; Watson A; Jandeleit-Dahm K; Burns WC; Thomas MC; Cooper ME; Kantharidis P Diabetes; 2011 Jan; 60(1):280-7. PubMed ID: 20952520 [TBL] [Abstract][Full Text] [Related]
17. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy. Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292 [TBL] [Abstract][Full Text] [Related]
18. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy. Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104 [TBL] [Abstract][Full Text] [Related]
19. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy. Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921 [TBL] [Abstract][Full Text] [Related]
20. MiR-130b increases fibrosis of HMC cells by regulating the TGF-β1 pathway in diabetic nephropathy. Ma Y; Shi J; Wang F; Li S; Wang J; Zhu C; Li L; Lu H; Li C; Yan J; Zhang X; Jiang H J Cell Biochem; 2019 Mar; 120(3):4044-4056. PubMed ID: 30260005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]